12
Participants
Start Date
January 1, 2017
Primary Completion Date
May 30, 2018
Study Completion Date
June 30, 2018
Emeramide
Lipophilic, membrane passing Metal chelator and anti oxidant
Placebo
14 days treatment with placebo
Lead Sponsor
EmeraMed
INDUSTRY